Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India
Abstract The current recommendations by Indian experts who are focused on the challenges in the management of patients with acute coronary syndrome (ACS) in rural areas, due to limited catheterization (CATH) lab facilities and interventional cardiologist coverage across the country, are described. 1...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2023-04-01
|
| Series: | Cardiology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40119-023-00312-x |
| _version_ | 1797817732255711232 |
|---|---|
| author | Saumitra Ray Bharat Shivdasani Jagdish Chander Mohan V. T. Shah Jagdish Hiremath Rajiv Karnik Bhupen Desai Hemant Madan Rajeev Garg Johann Christopher |
| author_facet | Saumitra Ray Bharat Shivdasani Jagdish Chander Mohan V. T. Shah Jagdish Hiremath Rajiv Karnik Bhupen Desai Hemant Madan Rajeev Garg Johann Christopher |
| author_sort | Saumitra Ray |
| collection | DOAJ |
| description | Abstract The current recommendations by Indian experts who are focused on the challenges in the management of patients with acute coronary syndrome (ACS) in rural areas, due to limited catheterization (CATH) lab facilities and interventional cardiologist coverage across the country, are described. 120 cardiologist experts drafted recommendations during ten advisory board meetings conducted from April to May 2022. Experts framed statements based on experience, collective clinical judgment from practical experience, and available scientific evidence regarding ACS. The consensus positioned fondaparinux as highly useful in non-CATH-lab-based hospitals for patients diagnosed with non-ST elevation acute coronary syndrome (NSTE-ACS) and ST elevation acute coronary syndrome (STE-ACS) patients who cannot be shifted to percutaneous coronary intervention (PCI)-capable centres, or for patients who are thrombolysed at peripheral centres. |
| first_indexed | 2024-03-13T08:57:47Z |
| format | Article |
| id | doaj.art-d040b0407c934f938805656fe46c3863 |
| institution | Directory Open Access Journal |
| issn | 2193-8261 2193-6544 |
| language | English |
| last_indexed | 2024-03-13T08:57:47Z |
| publishDate | 2023-04-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Cardiology and Therapy |
| spelling | doaj.art-d040b0407c934f938805656fe46c38632023-05-28T11:30:43ZengAdis, Springer HealthcareCardiology and Therapy2193-82612193-65442023-04-0112226127410.1007/s40119-023-00312-xClinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from IndiaSaumitra Ray0Bharat Shivdasani1Jagdish Chander Mohan2V. T. Shah3Jagdish Hiremath4Rajiv Karnik5Bhupen Desai6Hemant Madan7Rajeev Garg8Johann Christopher9AMRI HospitalJaslok HospitalInstitute of Heart and Vascular Disorders, Jaipur Golden HospitalDr. V T Shah Diagnostic Centre & ClinicHeart Transplant Department, Ruby Hall ClinicAsian Heart InstituteDesai Heart Care ClinicDharamshila Narayana Superspeciality HospitalAware Gleneagles Global HospitalsGurunanak Care HospitalAbstract The current recommendations by Indian experts who are focused on the challenges in the management of patients with acute coronary syndrome (ACS) in rural areas, due to limited catheterization (CATH) lab facilities and interventional cardiologist coverage across the country, are described. 120 cardiologist experts drafted recommendations during ten advisory board meetings conducted from April to May 2022. Experts framed statements based on experience, collective clinical judgment from practical experience, and available scientific evidence regarding ACS. The consensus positioned fondaparinux as highly useful in non-CATH-lab-based hospitals for patients diagnosed with non-ST elevation acute coronary syndrome (NSTE-ACS) and ST elevation acute coronary syndrome (STE-ACS) patients who cannot be shifted to percutaneous coronary intervention (PCI)-capable centres, or for patients who are thrombolysed at peripheral centres.https://doi.org/10.1007/s40119-023-00312-xAcute coronary syndromeAnticoagulantFondaparinuxPercutaneous coronary intervention |
| spellingShingle | Saumitra Ray Bharat Shivdasani Jagdish Chander Mohan V. T. Shah Jagdish Hiremath Rajiv Karnik Bhupen Desai Hemant Madan Rajeev Garg Johann Christopher Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India Cardiology and Therapy Acute coronary syndrome Anticoagulant Fondaparinux Percutaneous coronary intervention |
| title | Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India |
| title_full | Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India |
| title_fullStr | Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India |
| title_full_unstemmed | Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India |
| title_short | Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India |
| title_sort | clinical decision pathway for the use of fondaparinux in the management of acute coronary syndrome acs in hospitals with and without catheter laboratories an expert opinion from india |
| topic | Acute coronary syndrome Anticoagulant Fondaparinux Percutaneous coronary intervention |
| url | https://doi.org/10.1007/s40119-023-00312-x |
| work_keys_str_mv | AT saumitraray clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT bharatshivdasani clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT jagdishchandermohan clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT vtshah clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT jagdishhiremath clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT rajivkarnik clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT bhupendesai clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT hemantmadan clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT rajeevgarg clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia AT johannchristopher clinicaldecisionpathwayfortheuseoffondaparinuxinthemanagementofacutecoronarysyndromeacsinhospitalswithandwithoutcatheterlaboratoriesanexpertopinionfromindia |